1 / 2

Male Infertility Market is Expected to Reach $301.5 Million, Globally, by 2020

The inability of a couple to conceive within 12 months of unprotected intercourse is called infertility.

Download Presentation

Male Infertility Market is Expected to Reach $301.5 Million, Globally, by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Male Infertility Market Male Infertility Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $301.5 million by 2020, registering a CAGR of 5% during the period 2014-2020. Download the Sample Report @ http://bit.ly/2UPaCa8 Infertility in male is characterized by various infertility related problems such as low sperm count, presence of low motile sperm or azoospermia. The various causes of male infertility include stress, consumption of alcohol or drugs, smoking, obesity, environmental toxins, etc. These factors also act as driving factors of the male infertility market. When an individual is diagnosed with infertility, the person undergoes immense stress, embarrassment and guilt, which would further intensify the infertility problem. This is a major limitation of this market. The opportunity for the growth of this market is the increase in awareness levels among men and rising trend in medical tourism. The male infertility market is segmented based on techniques, namely DNA fragmentation, oxidative stress analysis, sperm agglutination test, sperm penetration test, microscopic examination, computer assisted semen analysis and others. The DNA fragmentation would be the highest revenue generating market by 2020 and is also expected to have the highest CAGR during the analysis period, when compared to the other segments in the techniques market. This is due to the accuracy level the test provides in identifying the level of infertility by measuring the level of DNA damage. The key companies profiled in the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions. Purchase Inquiry @ http://bit.ly/2DtJ0g1 Male Infertility Market Segments covered in the report: By Techniques DNA Fragmentation Technique  Oxidative Stress Analysis  Microscopic Examination  Sperm Penetration Assay  Sperm Agglutination  Computer Assisted Semen Analysis 

  2. Others  By Geography North America  Europe  Asia Pacific  RoW 

More Related